✦ LIBER ✦

Raloxifene: A new drug to prevent bone loss, atherosclerosis and breast cancer

✍ Scribed by Hirotoshi Morii

Book ID: 105555712
Publisher: Springer
Year: 1994
Tongue: English
Weight: 140 KB
Volume: 12
Category: Article
ISSN: 0914-8779
DOI: 10.1007/bf02383387

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Breast Cancer Metastasis and Drug Resist

Breast Cancer Metastasis and Drug Resistance || Erratum to: Bone Metastasis of Breast Cancer

✍ Ahmad, Aamir 📂 Article 📅 2013 🏛 Springer New York 🌐 English ⚖ 112 KB

This volume comprehensively covers recent prrogress in breast cancer research. In an effort to successfully treat breast cancer, it is imperative to a) fully understand the disease with all its heterogeneity, b) understand the factors that influence the metastasis of breast cancer to distant organs

Women’s interest in taking tamoxifen and

Women’s interest in taking tamoxifen and raloxifene for breast cancer prevention: response to a tailored decision aid

✍ Angela Fagerlin; Amanda J. Dillard; Dylan M. Smith; Brian J. Zikmund-Fisher; Ros 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 300 KB

RANK Ligand-targeted Therapy: A Novel Ap

RANK Ligand-targeted Therapy: A Novel Approach to Prevent Bone Loss and Fractures in Men with Prostate Cancer

✍ Matthew R. Smith 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 288 KB

Erratum to: Strength training stops bone

Erratum to: Strength training stops bone loss and builds muscle in postmenopausal breast cancer survivors: a randomized, controlled trial

✍ Kerri M. Winters-Stone; Jessica Dobek; Lillian Nail; Jill A. Bennett; Michael C. 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 140 KB

4–50 Zoledronic Acid Prevents Cancer Tre

4–50 Zoledronic Acid Prevents Cancer Treatment–Induced Bone Loss in Premenopausal Women Receiving Adjuvant Endocrine Therapy for Hormone-Responsive Breast Cancer: A Report From the Austrian Breast and Colorectal Cancer Study Group

✍ Jotwani, A.C.; Gralow, J.R. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Erratum to: Guidance for the prevention

Erratum to: Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper

✍ R. Rizzoli, J. J. Body, A. DeCensi, J. Y. Reginster, P. Piscitelli, M. L. Brandi 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 54 KB